N.J. U.S. Attorney: Former Chief Financial Officer of $21 Billion Biopharmaceutical Company Admits Insider Trading
May 18, 2023
May 18, 2023
NEWARK, New Jersey, May 18 -- The U.S. Attorney for the District of New Jersey, Philip R. Sellinger, issued the following news release on May 17, 2023:
The former chief financial officer for a biopharmaceutical company today admitted his role in an insider trading scheme, U.S. Attorney Philip R. Sellinger announced.
Usama Malik, 48, of Washington, D.C., pleaded guilty today before U.S. District Judge John Michael Vazquez in Newark federal court to Count One of an indict . . .
The former chief financial officer for a biopharmaceutical company today admitted his role in an insider trading scheme, U.S. Attorney Philip R. Sellinger announced.
Usama Malik, 48, of Washington, D.C., pleaded guilty today before U.S. District Judge John Michael Vazquez in Newark federal court to Count One of an indict . . .